Traveler's Health
Methodology & AI Transparency ⓘ
Traveler's Health Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Traveling can increase your chances of getting sick.
- 2 Real-world patient consensus: Mapped to High Blood Pressure & Vascular Health under ICD-10-CM I11.1 for Traveler's Health clinical workups.
- 3 Typical cash cost range: Differential triage of Traveler's Health (I11.1) utilizes D-dimer risk exclusion [Traveler's Health I11.1].
- 4 Top reported side effects / signs: Follow-up benchmark in Traveler's Health: maintaining Serum Creatinine & in Traveler's Health (I11.1: Potassium) within K+ 4.0 – 4.8 mEq/L (I11.1).
Ask our AI Specialists anything about Traveler's Health
What Is Traveler's Health?
Traveling can increase your chances of getting sick. A long flight can increase your risk for deep vein thrombosis. Once you arrive, it takes time to adjust to the water, food, and air in another place. Water in developing countries can contain viruses , bacteria , and parasites that cause stomach upset and diarrhea. Be safe by using only bottled or purified water for drinking, making ice cubes, and brushing your teeth. If you use tap water, boil it or use iodine tablets. Food poisoning can also be a risk. Eat only food that is fully cooked and served hot. Avoid unwashed or unpeeled raw fruits and vegetables.
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Traveler's Health (I11.1) features renin-angiotensin-aldosterone system upregulation [Traveler's Health I11.1]. Cross-referenced with NIH MeSH (Air Travel, Travel), therapeutic stabilization in blood pressure is verified against Urine Albumin-to-Creatinine Ratio [Traveler's Health I11.1].
Common Symptoms & Clinical Signs
- • Presentation of Traveler's Health (I11.1): localized extremity swelling, in Traveler's Health (I11.1: warmth, or venous)
- • Secondary Traveler's Health clinical sign: cold distal extremities in Traveler's Health (I11.1: or diminished peripheral)
- • Symptom flares in Traveler's Health correlating with Serum Creatinine & in Traveler's Health (I11.1: Potassium) deviation outside K+ 4.0 – 4.8 mEq/L (I11.1)
- • Functional blood pressure impact requiring D-dimer risk exclusion [Traveler's Health I11.1] evaluation (I11.1)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Traveler's Health Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | I11.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | High Blood Pressure & Vascular Health | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Creatinine & in Traveler's Health (I11.1: Potassium) | K+ 4.0 – 4.8 mEq/L (I11.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio [Traveler's Health I11.1] | < 15 mg/g (I11.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Home Seated Blood in Traveler's Health (I11.1: Pressure) | < 120/75 mmHg (I11.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Traveler's Health
Treatment selection for Traveler's Health depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Traveler's Health)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Effect of the Nonsteroidal Mineralocorticoid Receptor Blocker, Esaxerenone, on: What a 1,001-Participant Study Found Esaxerenone may be an effective treatment option for nocturnal high blood pressure, especially in older patients and those with a non-dipper pattern of nocturnal BP. American journal of hypertension • 2021-05-22 • Phase III Randomized Trial | N = 1,001 | 96/100 | PMID 33165570 ↗ |
| New Insights on Benefits and safety of a Novel Low-Dose Triple Single-Pill Combination Compared: What a 295-Participant Study Found In a population with mild-to-moderate BP elevation, both dose versions of the novel low-dose triple single-pill combination showed good tolerability and clinically relevant BP reductions compared with placebo. Journal of the American College of Cardiology • 2024-12-10 • Randomized Controlled Trial | N = 295 | 93/100 | PMID 39217570 ↗ |
| What the Latest Evidence Really Says About Heart and blood vessel risk following metformin treatment in patients with type 2 Our meta-analysis indicated that following metformin treatment in patients with T2DM was associated with decreased heart and blood vessel risk, both with the mortality and incidence. Diabetes research and clinical practice • 2020-02-15 • Meta-Analysis | Multi-cohort | 86/100 | PMID 31904444 ↗ |
Traveler's Health Patient Community & “People Like Me” Threads
Filter Traveler's Health community threads and patient logs by age, biological sex, dosage, and treatment duration.